Webcast CME

Basic and Clinical Immunology Webcast Series

 

Understanding B and T Cell Targeting in Autoimmune Diseases

Print this Content

Release date: April 8, 2020
Expiration date: April 8, 2022

Estimated Time of Completion: 15 minutes

Description

The Basic and Clinical Immunology Webcast Series features webcasts by a faculty of experts and summarizes talks presented during the 8th Annual Basic and Clinical Immunology: What Is New and Hot in Immunology Symposium. Designed for busy clinicians who desire to increase their declarative and procedural knowledge in the field of IMIDs, data presented are essential to understanding their clinical application and predicting and preventing toxicity.

Understanding B and T Cell Targeting in Autoimmune Diseases webcast highlights roles of B cells in autoimmune pathogenesis.

Learning Objectives

  1. Review the potential roles of B cells in autoimmune pathogenesis.
  2. Discuss recent progress in early state clinical trials for the development of new agents that target B cells and T cells for the treatment of SLE.

Target Audience

The educational activity is designed for rheumatologists, dermatologists, infectious disease, allergists, clinical immunologists, and specialists in integrative medicine, preventive medicine, wellness, primary care and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Gregg Silverman, MD
Associate Director, Division of Rheumatology
Professor of Medicine and Pathology
NYU School of Medicine
New York, NY

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Leonard H. Calabrese, DO Abbvie Pharmaceuticals, BMS, Genentech/Roche, Janssen, Novartis Consulting
Teaching and Speaking
Crescendo Teaching and Speaking
GSK, Horizon Pharma, Pfizer, Regeneron, Sanofi Aventis, UCB Consulting

The following faculty have indicated he has have no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:

Gregg Silverman, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

AbbVie, Inc.
Bristol-Myers Squibb
Genentech, Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:

AbbVie, Inc.
Bristol-Myers Squibb
Genentech, Inc.
Gilead
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Pfizer, Inc.


This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and Cleveland Clinic's RJ Fasenmyer Center for Clinical Immunology.